Aimmune Therapeutics
Why Robinhood?
You can watch AIMT and buy or sell other stocks, ETFs, and their options commission-free!About AIMT
Aimmune Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the research and development of desensitization treatments for peanut and other food allergies. Its portfolio includes the characterized oral desensitization immunotherapy system.
AIMT Key Statistics
Stock Snapshot
As of today, Aimmune Therapeutics(AIMT) shares are valued at $34.49. The company's market cap stands at 2.26B, with a P/E ratio of -7.68.
On 2026-03-18, Aimmune Therapeutics(AIMT) shares started trading at —, with intraday highs of — and lows of —.
Trading volume for Aimmune Therapeutics(AIMT) stock has reached 0, versus its average volume of 1.45M.
The stock's 52-week range extends from a low of $10.09 to a high of $37.00.
The stock's 52-week range extends from a low of $10.09 to a high of $37.00.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.